IOL Chemicals and Pharmaceuticals Limited

NSE: IOLCP · Unclassified

₹183.29-3.06%06 Nov 2026

Ask the data

Instant answers about IOL Chemicals and Pharmaceuticals Limited — computed from its filings, no language model

Market cap₹5,380 cr

Current price₹183.29

High / Low₹220 / ₹68

P/E26.5

P/B2.79

Book value₹65.6

ROE10.6%

ROCE13.6%

Debt / equity0.10

Dividend yield0.55%

EPS (TTM)₹6.92

Face value₹2

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

	FY22	FY23	FY24	FY25	FY26
Revenue	2,184	2,217	2,133	2,079	2,319
EBITDA	258	226	231	202	269
Operating margin	11.8%	10.2%	10.8%	9.7%	11.6%
Interest	8	16	16	15	15
Depreciation	43	46	63	72	80
Profit before tax	225	189	182	138	184
Tax	57	50	47	37	47
Net profit	168	139	134	101	138
EPS ₹	28.56	23.70	22.90	3.44	4.69
Operating cash flow	93	122	290	179	214
Capex	153	212	274	214	173
Dividend paid	35	24	29	23	29
Total assets	—	2,022	2,244	2,382	2,587
Equity	—	1,508	1,612	1,688	1,799

Quarterly performance

last 19 quarters · ₹ crore

showing latest 8 of 19 periods

	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
Revenue	572	565	541	523	587	563	545	520	504	502	526	523	528	552	568	580	619	756	795
Operating profit	45	56	32	43	95	73	64	44	50	51	42	47	63	62	57	57	92	103	109
Operating margin	7.9%	9.9%	5.9%	8.2%	16.2%	12.9%	11.8%	8.5%	9.8%	10.2%	7.9%	9.0%	11.9%	11.3%	10.1%	9.9%	14.9%	13.7%	13.8%
Other income	7	5	5	7	9	7	7	8	8	7	6	4	5	7	7	5	2	8	6
Interest	2	3	4	5	5	4	4	4	3	2	4	4	4	4	3	4	3	4	5
Depreciation	11	11	11	12	12	14	16	16	16	17	18	19	19	20	20	20	20	21	22
Profit before tax	39	47	22	33	87	61	51	32	37	40	26	28	45	46	40	28	71	87	87
Tax	9	12	6	9	22	15	13	9	10	10	7	7	13	12	11	7	18	22	22
Net profit	30	35	16	24	65	46	38	23	28	30	19	21	31	34	30	21	53	64	65
EPS ₹	5.07	5.91	2.71	4.05	11.03	7.81	6.45	3.93	4.71	5.11	3.26	3.50	1.07	1.16	1.02	0.70	1.81	2.20	2.21
Revenue YoY	—	—	—	—	2.6%	-0.3%	0.7%	-0.6%	-14.2%	-10.8%	-3.6%	0.6%	4.7%	9.8%	7.9%	10.9%	17.4%	37.1%	40.1%
Profit YoY	—	—	—	—	117.7%	32.3%	138.0%	-3.0%	-57.4%	-34.6%	-49.4%	-11.0%	13.8%	13.2%	56.5%	0.2%	69.2%	89.8%	117.1%

Earlier results (standalone, Sep '07 – Dec '21)

₹ crore · from BSE, before the NSE XBRL filings begin

IOL Chemicals and Pharmaceuticals Limited reports consolidated figures above. Quarterly consolidated results only became mandatory in India in 2019, so the earlier history available is the standalone company only (excluding subsidiaries). It is shown separately so the two bases are never mixed.

Full years

showing latest 8 of 11 periods

	FY09†	FY12†	FY13†	FY14†	FY15†	FY16†	FY17†	FY18†	FY19†	FY20†	FY21†
Revenue	304	473	486	565	386	582	711	1,001	1,685	1,894	1,967
Operating profit	36	71	92	97	13	53	103	124	408	574	592
Operating margin	11.8%	15.0%	18.8%	17.2%	3.3%	9.0%	14.4%	12.4%	24.2%	30.3%	30.1%
Other income	0	0	0	0	0	0	—	2	12	16	24
Interest	15	43	57	60	59	61	67	64	51	21	6
Depreciation	10	24	31	32	29	30	30	30	32	36	39
Profit before tax	11	4	3	5	-75	-39	5	31	336	533	571
Tax	-2	-1	1	2	-9	-3	1	4	99	172	127
Net profit	13	5	2	3	-67	-36	4	28	237	361	445

Quarters

showing latest 8 of 55 periods

	SEP '07†	DEC '07†	JUN '08†	SEP '08†	DEC '08†	MAR '09†	JUN '09†	SEP '09†	DEC '09†	JUN '10†	SEP '10†	DEC '10†	JUN '11†	SEP '11†	DEC '11†	MAR '12†	JUN '12†	SEP '12†	DEC '12†	MAR '13†	JUN '13†	SEP '13†	DEC '13†	MAR '14†	JUN '14†	SEP '14†	DEC '14†	MAR '15†	JUN '15†	SEP '15†	DEC '15†	MAR '16†	JUN '16†	SEP '16†	DEC '16†	MAR '17†	JUN '17†	SEP '17†	DEC '17†	MAR '18†	JUN '18†	SEP '18†	DEC '18†	MAR '19†	JUN '19†	SEP '19†	DEC '19†	MAR '20†	JUN '20†	SEP '20†	DEC '20†	MAR '21†	JUN '21†	SEP '21†	DEC '21†
Revenue	81	85	83	80	68	74	88	89	86	92	89	102	114	107	131	122	126	106	117	136	140	155	139	131	121	122	68	75	137	158	143	142	162	173	183	193	233	218	263	288	362	423	478	422	493	449	511	441	460	533	513	460	519	538	555
Operating profit	9	10	9	11	7	9	8	8	13	16	16	18	18	18	19	16	23	22	24	22	24	25	24	24	25	7	-10	-9	2	8	17	25	26	25	26	26	27	30	32	35	40	75	136	157	145	133	160	137	152	171	157	111	110	44	59
Operating margin	11.7%	11.9%	10.8%	13.5%	10.2%	12.6%	9.6%	8.8%	14.8%	17.6%	18.2%	17.6%	15.6%	17.2%	14.4%	13.2%	18.4%	21.1%	20.4%	16.2%	17.5%	16.2%	17.0%	18.2%	20.5%	5.6%	-15.1%	-11.9%	1.6%	5.2%	11.9%	17.6%	15.8%	14.8%	14.0%	13.3%	11.7%	13.6%	12.3%	12.0%	11.0%	17.8%	28.3%	37.2%	29.3%	29.6%	31.2%	31.0%	33.1%	32.1%	30.7%	24.1%	21.2%	8.1%	10.7%
Other income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	—	—	0	0	0	0	1	4	6	1	2	3	3	4	5	6	4	8	6	6	11	9
Interest	3	4	4	4	3	4	4	3	4	9	9	10	10	11	12	10	14	14	15	14	15	16	14	15	15	15	14	15	15	15	15	16	17	17	17	17	17	17	16	15	16	14	13	9	8	6	4	3	2	1	1	1	2	2	2
Depreciation	1	2	2	3	3	2	3	3	3	6	6	6	6	6	6	6	8	8	8	8	8	8	8	8	8	6	8	7	7	7	7	7	7	7	8	7	7	8	8	8	8	8	8	8	9	9	9	9	9	10	10	10	10	11	11
Profit before tax	5	4	3	4	1	3	2	2	6	2	1	2	1	2	1	-0	1	1	1	0	1	2	1	1	2	-14	-32	-31	-20	-15	-6	2	1	1	1	2	3	6	10	13	20	59	115	143	131	121	151	130	147	165	154	106	90	42	55
Tax	2	1	1	0	0	-3	1	1	0	1	0	1	0	0	0	-2	0	0	0	0	0	0	1	0	1	-5	-2	-3	-2	-2	0	0	0	0	0	0	0	1	1	1	5	20	33	41	46	34	53	40	19	38	39	31	23	11	15
Net profit	3	3	2	4	1	6	1	2	6	1	1	1	1	1	1	2	1	0	0	0	1	1	1	1	1	-10	-30	-28	-18	-13	-6	1	1	1	1	2	3	4	9	11	14	38	82	102	85	88	98	90	128	127	115	75	67	31	40
EPS ₹	2.76	2.36	1.43	3.05	0.58	3.71	0.60	0.74	3.04	0.44	0.42	0.61	—	0.53	0.29	0.66	0.26	0.19	0.13	0.03	0.32	0.41	0.21	0.28	0.42	-2.88	-7.88	-6.38	-3.72	-2.51	-1.14	0.20	0.13	0.17	0.19	0.26	0.53	0.79	1.56	2.05	2.56	6.84	14.63	18.08	15.00	15.42	17.22	15.87	22.30	21.61	19.54	12.76	11.41	5.26	6.82
Revenue YoY	—	—	—	-0.8%	-20.5%	—	6.4%	11.8%	27.2%	3.8%	-0.0%	18.4%	24.2%	19.2%	28.3%	—	11.3%	-0.5%	-10.3%	11.5%	10.7%	46.3%	18.4%	-3.6%	-13.5%	-21.7%	-51.1%	-42.5%	13.2%	30.3%	111.1%	89.3%	18.2%	8.9%	27.8%	35.7%	43.6%	26.2%	43.3%	48.8%	55.3%	94.2%	82.1%	46.9%	36.2%	6.2%	6.9%	4.5%	-6.6%	18.8%	0.3%	4.3%	12.7%	0.8%	8.2%
Profit YoY	—	—	—	25.3%	-71.9%	—	-34.6%	-62.7%	643.0%	-20.0%	-37.4%	-77.0%	-3.0%	41.2%	-52.4%	—	-28.9%	-65.0%	-50.0%	-95.9%	18.8%	122.9%	68.6%	1057.1%	52.4%	-1011.2%	-5200.0%	-3564.2%	-1535.2%	—	—	—	—	—	—	32.7%	308.2%	352.0%	762.7%	666.0%	383.6%	766.8%	834.5%	784.7%	492.1%	128.4%	19.2%	-11.2%	49.5%	44.8%	17.1%	-16.6%	-47.5%	-75.7%	-65.1%

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 16 periods

	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
ROE	7.2%	9.2%	10.0%	10.8%	10.8%	8.3%	7.4%	6.0%	5.9%	6.0%	6.2%	6.6%	6.6%	7.7%	9.3%	10.6%
ROCE	10.1%	12.9%	13.9%	15.2%	15.1%	12.0%	10.6%	8.3%	8.1%	8.5%	8.9%	9.1%	9.1%	10.3%	12.4%	13.6%
Net margin	4.7%	6.3%	6.8%	7.8%	7.7%	6.3%	5.7%	4.9%	4.7%	4.9%	4.9%	5.3%	5.2%	5.9%	6.7%	7.4%
EBITDA margin	8.0%	10.2%	10.9%	12.4%	12.5%	10.8%	10.1%	9.1%	9.2%	9.7%	10.0%	10.5%	10.7%	11.6%	12.3%	13.2%
Debt / equity	0.06	0.05	0.05	0.04	0.04	0.02	0.02	0.08	0.08	0.07	0.07	0.09	0.09	0.07	0.07	0.10
Interest coverage	11.07	12.45	12.93	13.93	14.18	12.28	12.19	10.64	10.23	10.35	9.55	10.78	11.30	13.67	17.16	18.11
Asset turnover	1.10	1.10	1.10	1.07	1.06	0.95	0.92	0.91	0.91	0.87	0.89	0.90	0.92	0.90	0.98	0.97

Balance sheet

equity vs borrowings over time · ₹ crore

showing latest 6 of 9 periods

	SEP '22	MAR '23	SEP '23	MAR '24	SEP '24	MAR '25	SEP '25	MAR '26	SEP '26
Share capital	59	59	59	59	59	59	59	59	59
Other equity / reserves	1,383	1,449	1,531	1,553	1,601	1,629	1,693	1,740	1,867
Total equity	1,442	1,508	1,590	1,612	1,659	1,688	1,751	1,799	1,926
Borrowings	88	80	59	33	128	117	159	132	194
Current liabilities	512	456	430	560	530	610	574	690	801
Non-current liabilities	57	58	62	73	76	84	88	98	104
Total assets	2,011	2,022	2,081	2,244	2,265	2,382	2,413	2,587	2,831
Property, plant & equipment	565	751	844	922	999	1,158	1,128	1,165	1,171
Capital work-in-progress	146	81	40	100	122	21	64	94	189
Investments	2	20	20	3	21	21	21	21	21
Inventories	352	326	316	425	376	361	384	371	464
Receivables	483	505	490	471	465	514	523	603	689
Cash & equivalents	13	1	3	8	18	78	27	65	9

Cash flow

annual · ₹ crore · line = free cash flow

	FY22	FY23	FY24	FY25	FY26
Cash from operations	93	122	290	179	214
Cash from investing	-120	-120	-191	-154	-198
Cash from financing	-2	-4	-92	46	-29
Capex	153	212	274	214	173
Free cash flow	-60	-90	16	-35	41
Dividends paid	35	24	29	23	29

Where the assets sit

Sep '26 · ₹ crore

Fixed assets (PPE)

₹1,171 cr41%

CWIP

₹189 cr7%

Investments

₹21 cr1%

Inventories

₹464 cr16%

Receivables

₹689 cr24%

Cash & equivalents

₹9 cr0%

Other assets

₹287 cr10%

Peer comparison

largest in Unclassified · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Avantel Limited	36,86,04,549	138.69	—	1059360.68	0.0%
Ducol Organics And Colours Limited	19,55,275	120.00	—	20089.13	0.0%
Jio Platforms Limited	12,57,181	1,406.40	—	3.57	—
SBI Funds Management Limited	1,01,750	499.55	—	—	—
Tamilnadu Telecommunication Limited	91,314	9.93	—	—	—
Manipal Health Enterprises Limited	76,294	646.70	—	—	—
INDO-MIM Limited	59,042	1,219.50	—	—	—
AvenuesAI Limited	45,138	129.25	153.6	9.51	6.2%
Dhoot Transmission Limited	32,761	1,601.60	—	8.11	—
3M India Limited	31,071	27,570.00	53.8	17.57	32.7%
IOL Chemicals and Pharmaceuticals Limited	5,380	183.29	26.5	2.79	10.6%

StoxGud checklist: Neutral setup · 6/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-16.8%

6 months+87.4%

1 year+93.6%

3Y CAGR+27.8%

5Y CAGR+10.8%

10Y CAGR+22.1%

50-day avg₹194.34

200-day avg₹131.68

RSI (14)43

FAQs

What is the share price of IOL Chemicals and Pharmaceuticals Limited?

IOL Chemicals and Pharmaceuticals Limited (IOLCP) closed at ₹183.29 on NSE on 06 Nov 2026.

What is the market cap of IOL Chemicals and Pharmaceuticals Limited?

₹5,380 crore at the latest close.

What is the P/E ratio of IOL Chemicals and Pharmaceuticals Limited?

26.5, on trailing-twelve-month earnings from its filings.

How fast is IOL Chemicals and Pharmaceuticals Limited growing?

IOL Chemicals and Pharmaceuticals Limited: revenue has compounded at 1.5% a year over three years; net profit at -0.4% a year. Latest-quarter revenue is up 40.1% year on year, profit up 117.1%.

How profitable is IOL Chemicals and Pharmaceuticals Limited?

On a trailing-twelve-month basis return on equity is 10.6%, return on capital employed 13.6%, operating margin 13.2%, net margin 7.4%.

How much debt does IOL Chemicals and Pharmaceuticals Limited have?

IOL Chemicals and Pharmaceuticals Limited is lightly geared: debt to equity is 0.10 with borrowings of ₹194 cr against cash of ₹9 cr (balance sheet of 2026-09-30). Operating profit covers interest 18.1 times.

Financials parsed from IOL Chemicals and Pharmaceuticals Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from MAR '22, annual from FY22, balance sheet from Sep '22. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.